The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 08, 2011
Filed:
Apr. 26, 2002
Yasuhiro Tanaka, Kanagawa, JP;
Kohichi Fujita, Kanagawa, JP;
Yoshitomo Chujoh, Kanagawa, JP;
Syunsuke Fukuda, Kanagawa, JP;
Yuka Ikenoue, Kanagawa, JP;
Tomoyuki Tagami, Kanagawa, JP;
Akira Chiba, Kanagawa, JP;
Ariko Kodaira, Kanagawa, JP;
Hideki Matsumoto, Kanagawa, JP;
Tadakiyo Nakagawa, Kanagawa, JP;
Tatsuhiro Yamada, Kanagawa, JP;
Manabu Suzuki, Kanagawa, JP;
Masahiro Murata, Kanagawa, JP;
Yasuhiro Tanaka, Kanagawa, JP;
Kohichi Fujita, Kanagawa, JP;
Yoshitomo Chujoh, Kanagawa, JP;
Syunsuke Fukuda, Kanagawa, JP;
Yuka Ikenoue, Kanagawa, JP;
Tomoyuki Tagami, Kanagawa, JP;
Akira Chiba, Kanagawa, JP;
Ariko Kodaira, Kanagawa, JP;
Hideki Matsumoto, Kanagawa, JP;
Tadakiyo Nakagawa, Kanagawa, JP;
Tatsuhiro Yamada, Kanagawa, JP;
Manabu Suzuki, Kanagawa, JP;
Masahiro Murata, Kanagawa, JP;
Ajinomoto Co., Inc., Tokyo, JP;
Abstract
A pharmaceutical composition containing a heterocyclic compound of the formula (I) wherein each symbol is as defined in the specification, an isomer thereof, a solvate thereof or a pharmaceutically acceptable salt thereof as an active ingredient has a superior TNF-α production suppressing action. Accordingly, it is useful for the prophylaxis or treatment of various diseases caused by abnormal production of TNF-α.